Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a prospective study in which a process of identifying and reducing heart failure (HF) risk will be applied to cancer survivors \>65 years old with chemotherapy \>10 years ago. The overall goal of this study to identify the feasibility and value of risk-guided cardiac rehabilitation (exercise, risk factor modification, and behavioural support) as a component of survivorship care.
Epistemonikos ID: 7a04bd5827e88cc257f52ca8e969343b1acc4f5c
First added on: May 09, 2024